Skip to main content

Table 3 Summary of CNV types and numbers in primary tumor and metastatic samples of 5 patients

From: Genomic alterations in gastric cancers discovered via whole-exome sequencing

ID Num (S-Gain) Num (S-Loss) Num (L-Gain) Num (L-Loss)
P1 113 39 61 4
P2 791 446 9 70
P3 1241 19 238 1
P4 1093 5 395 25
P5 22 109 131 82
Total 3260 618 834 182
Status Num Main locus CN
Unique S-Gain 2601 1p12; 1p13; 1q21; 1q23; 1q32; 1q42; 11q13; 13q12; 13q11; 13q22; 13q32; 13q33; 14q21; 14q22; 5p12;17p13; 17q21; 5p13; 5p15; 6p21; 6p22; 7q11; Xp22 2~ 16.67
S-Loss 332 4q32; 4q33; 4q35; 9p21; 9p22; 9p23; 9p24; 11p15; 16p13; 18p11 0.52~ 2
L-Gain 580 1p11; 1q21; 10p12; 10q11; 11q13; 12p13; 14q32; 15q13; 16p13; 17q11; 20q11; 20q11; 20q13 2~ 7.04
L-Loss 47 1q21; 10q11; 16p13; 2p24; 22q11; 8p23 0.41~ 2
Common S-Gain
L-Gain
279 1q21; 11q13; 14q24; 17p13; 17q12; 17q21; 17q24; 19p13; ap23; 21q22; 4q12; 7p22; 7q11; 8p23; 9p12; 9q12; 9p13; 9q31; 2.00~ 7.04
S-Loss
L-Loss
52 1q21; 10q11; 11p11; 11q12; 15q24; 16p13; 16p12; 17q12; 2q13; 14q11; 22q11; 5q13; 1p36; 5q35; 6p21; 8p23; 9p21;
9p12; 9p11.2
0.11~ 1.42
S-Loss
L-Gain
1 7q22.1 0.91~ 1.12
3.42~ 7.04
  1. P1~P5 patient ID, S primary tumor tissue, L lymph node metastatic tissue, CNV copy number variation, Num gene numbers, S-Gain CNV gains of primary tumor tissues. S-Loss, CNV losses of primary tumor tissues. L-Gain, CNV gains of lymph node metastatic tissues. L-Loss, CNV losses of lymph node metastatic tissues. CN copy number
\